Ozempic
The gold standard. Provider-approved.
Ozempic (semaglutide 0.5mg–2mg) is the FDA-approved GLP-1 receptor agonist that has transformed metabolic medicine. Originally approved for Type 2 diabetes, its profound effects on weight, cardiovascular health, and metabolic function have made it one of the most sought-after treatments in modern medicine. Through Reclaimed, access is provider-supervised and fully compliant.
Key Benefits
- ✓FDA-approved with extensive long-term safety data
- ✓Average weight loss of 10–15% in clinical trials
- ✓Significant cardiovascular risk reduction
- ✓Improved HbA1c and fasting glucose
- ✓Once-weekly convenient dosing
- ✓Provider-supervised for optimal results
Quick Facts
Semaglutide, the active ingredient in Ozempic, has a longer half-life than earlier GLP-1 medications — allowing once-weekly dosing while maintaining consistent receptor activation. It reduces appetite by acting on GLP-1 receptors in the hypothalamus (the brain's hunger control center), slows gastric emptying, and significantly reduces the reward response to food. Clinical trials showed an average weight loss of 14.9% over 68 weeks.
More from Weight Loss
You Might Also Like
All prescription treatments require approval from a licensed healthcare provider. Results may vary. This product has not been evaluated by the FDA for the specific indications described. Reclaimed is a telehealth platform — we facilitate connections between patients and licensed providers, not the practice of medicine directly. Please consult your provider with any questions about your treatment.